Evidence-based recommendations compare CABG and PCI for coronary artery disease in STEMI and NSTEMI patients, highlighting implications for multivessel disease management.
Coronary artery disease patients suffering from ST-elevation myocardial infarction (STEMI) or non-STEMI (NSTEMI) require rapid decision on invasive therapy relying on state-of-the-art concepts. This article provides evidence-based recommendations on the choice between, or the combination of, the mechanistically different options, coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI)-with a special focus on multivessel disease patients. Furthermore, strategies of modern CABG in STEMI and NSTEMI patients are presented.
No takes yet. Share an insight, caveat, or question.
Alexander Assmann (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: